ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugBlueprint Medicines (Switzerland) GmbH
Blueprint Medicines (Switzerland) GmbH Logo
Verified· 2 sources

Blueprint Medicines (Switzerland) GmbH

Summary

About the company

Blueprint Medicines is a pharmaceutical company specializing in the development and marketing of innovative medicines. The company's core activity is the research, development and marketing of precision medicines, particularly for the treatment of cancer and other serious diseases. The company focuses on developing medicines that target specific molecular mechanisms, enabling more effective and safer treatment of patients.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered6
Medicines
Medicines with avapritinib, including AYVAKIT and AYVAKYT; approved uses in indolent and advanced systemic mastocytosis and gastrointestinal stromal tumour with PDGFRA exon 18 mutation.
Clinical development
Clinical programs and studies for systemic mastocytosis, gastrointestinal stromal tumour and other mast cell-mediated diseases; includes ongoing and completed clinical trials.
Early access to investigational medicines
Early access to investigational medicines for qualified physicians in serious or immediately life-threatening diseases when standard therapies are exhausted and clinical trials are not suitable.
Investigator-sponsored research
Support for independent clinical and non-clinical studies, including funding and product or material support, mainly focused on systemic mastocytosis and mast cell disorders.
Independent medical education
Grants for accredited and non-accredited education for healthcare professionals, patients, caregivers and communities; including live formats, educational materials and publications.
Collaborations and licenses
Strategic partnerships, collaboration agreements and licensing transactions for the development and commercialisation of medicines, including regional and global rights to selected programs.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Comparisons

Blueprint Medicines (Switzerland) GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Blueprint Medicines (Switzerland) GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Blueprint Medicines (Switzerland) GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Baarerstrasse 8
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-499.149.707
Founded
2018 · 8 years
Last commercial register change
July 30, 2026
Employees
51 to 100

Knowledge

No knowledge articles yet

Once Blueprint Medicines (Switzerland) GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

AS
Alnylam Switzerland GmbH
Zug
AP
Azurity Pharmaceuticals Switzerland GmbH
Zug
NG
Neopharmed Gentili Schweiz GmbH
Zug
QP
Quercis Pharma AG
Zug
C(
Cytokinetics (Switzerland) GmbH
Zug
SI
Sarepta International Holdings GmbH
Zug
TP
Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug
Zug
ST
SpringWorks Therapeutics Europe GmbH
Zug